Stocks To Buy Now Blog

All posts by Christopher

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Named Exclusive Water Partner for Canada’s Country Music Week 2021; BevCanna Named One of 101 Top Food and Beverage Startups and Companies in Canada

  • BevCanna Enterprises announced that its in-house brand, TRACE was designated as the exclusive water partner for the Country Music Week 2021
  • The TRACE brand features a range of products sourced from springs located deep within the Rocky Mountains; the product range includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water and Natural Flavor Sparkling Spring Water among others
  • BevCanna Enterprises separately announced that it has been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada
BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, recently announced that its mineral water brand, TRACE, had been designated as the exclusive water partner for the Country Music Week 2021. Hosted by the Canadian Country Music Association in London, Ontario last Nov. 26-20, the event sought to celebrate the development of the country music genre in Canada, culminating in the 2021 CCMA Awards Show, which was broadcast in a live special last Nov. 29, 2021. As the exclusive water partner of the Country Music Week 2021 and the 2021 CCMA Awards, TRACE products were available in all official welcome packages, could be found backstage at CCMA-sanctioned events and available for purchase at all main points of sale. Moreover, TRACE branding could be found on all menu listings throughout Country Music Week 2021. “We’re thrilled to partner with the CCMA on providing TRACE alkaline water for Country Music Week 2021 and the 2021 CCMA Awards,” said Melise Panetta, President of BevCanna. “As we continue to focus on expanding national awareness of the TRACE product, this is an excellent opportunity for us to reach Canadian country music fans — a growing demographic that is a strong fit for the TRACE brand.” BevCanna Enterprise’s TRACE brand features products painstakingly created using the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels. Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer several key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness. As of today, the TRACE line of products includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D, as well as Plant-Based Mineralized Immune Support Shots. BevCanna Enterprises has not rested on its laurels however, with the company recently named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada, a media company that focuses on the latest innovations, breakthroughs and greatest companies across Canada. BevCanna was also included in the list of the Top 101 Cannabis Startups and Companies in Canada, a list of innovators and growth companies within the Canadian cannabis industry (https://ibn.fm/A4tDy). “It’s both an honor and a reflection of the BevCanna team’s expertise and dedication to be included within the sphere of other premier Canadian food and beverage companies, including Ritual, Goodfood, Flow Water, Chef’s Plate and David’s Tea,” noted Marcello Leone, CEO of BevCanna. “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Ideally Positioned as Ammonia Gains Attention as a Solution to the Aviation Industry’s CO2 Emissions Problems

  • Commercial aviation accounted for about 2.7% of the world’s human-induced emissions in 2019
  • The aviation industry is one of the fastest growing (https://ibn.fm/Jilzk), meaning emissions will only increase in future
  • To meet the targets stipulated in the Paris Agreement (https://ibn.fm/hN0cs), the industry will need to move away from fossil fuels entirely; green ammonia is emerging as one of the alternatives
  • A consortium domiciled in the U.K. is developing a sustainable, low-emission propulsion system for airplanes that will use a blend of ammonia and hydrogen as a combustible fuel
  • FuelPositive, through its proprietary system, produces green ammonia in a process that significantly reduces CO2 emissions associated with traditional NH3 production
According to a report by the International Council on Clean Transportation (“ICCT”), commercial aviation emitted 920 million tons of CO2 in 2019, up from 903 million tons in 2018 (https://ibn.fm/ecyqd). Based on the 2019 figure, commercial aviation accounted for about 2.7% of all human-caused emissions, considering that the CO2 emissions in 2019 totaled roughly 33 billion tons. Although aviation is a small contributor to global greenhouse emissions compared to other sectors, a BBC Future Planet article points out that it is also one of the fastest growing (https://ibn.fm/pTRE1). “With COVID-19, flights and passenger numbers plummeted, but the number of people flying is expected to return to 2019 levels within a few years and continue to grow. All this means that we need to start doing far more on aviation emissions, and fast. But bar gradually rising efficiency in planes, little progress has been made so far on how to actually decarbonize airplanes,” the article notes. Citing the Paris Agreement on climate change, which encapsulates ambitious plans to cut carbon emissions, the article states that aviation will need to move away from fossil fuels entirely in the long term to limit global warming. In line with this goal, the write-up explores several ways the industry can be kinder to the planet. These include switching the fuel to alternatives such as sustainable aviation fuels (“SAFs”) and synthetic fuels, building more efficient planes, optimizing flight routes, and, finally, enforcing policy measures. Under the alternative fuels option, green ammonia (“NH3”) has increasingly taken center stage. In August last year, a consortium made up of the United Kingdom’s Science and Technology Facilities Council (“STFC”) and Reaction Engines finalized a concept study that explored the practicality of using NH3 as a jet aviation fuel. The study paired heat exchanger technology with advanced NH3 catalysts in the hope of producing a sustainable, low-emission propulsion system (https://ibn.fm/JCZOk). According to Reaction Engines, ammonia’s energy density is high enough that planes would not require significant modifications. Designed to make ammonia use more economically viable than before, the engine (propulsion system), could be retrofitted in a relatively short time and would not require an entirely new electric powertrain. According to a New Atlas article (https://ibn.fm/IPKhX), “The heat exchanger would capture heat from a jet engine’s exhaust and use it to power a cracking reactor. The reactor would catalytically convert pure ammonia into an ammonia-hydrogen blend that’ll work as an easily combustible fuel that’s more or less a drop-in replacement for jet fuel.” Unfortunately, burning ammonia produces nitrous oxides that are harmful to the environment as they contribute to acid rain and smog formation. It is hoped that the consortium will take care of these issues in the same way FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a company committed to clean energy solutions, has dealt with the CO2 emissions linked to the generation of grey ammonia. Traditionally produced (“grey”) ammonia is generated through the Haber-Bosch process, in which nitrogen and hydrogen molecules react. This highly energy-intensive process, which consumes about 1% of the world’s total energy production, releases roughly 500 million tons of CO2 – 1.8% of total CO2 emissions from human activities globally. Yet, these figures do not even account for emissions from the on-site production of hydrogen, which is extracted from natural gas (methane) in a resource-intensive process – producing 1 ton of H2 requires 9 tons of water (https://ibn.fm/yYu4n) – that also emits large quantities of CO2. In contrast, FuelPositive’s proprietary system produces green ammonia from sustainable electricity, water, and air, at a fraction of the cost of delivering grey NH3. According to the company’s case study conducted in Manitoba, Canada, its system is about 40% cheaper (https://ibn.fm/yJlxE). In addition, it requires less energy to produce NH3 on-site, as and when needed. With the first prototype expected to be ready to deploy in the summer of 2022, researchers such as the consortium developing a propulsion system for airplanes can significantly benefit from FuelPositive’s modular and easily scalable NH3 production system. This would, in fact, conform with NHHH’s commitment to clean energy solutions, such as green ammonia, for use in a variety of applications. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Inches Closer to iSTRYM’s Commercial Deployment; Announces Dr. Doron Sagman’s Appointment as CMO; and Avails Recent Life Sciences Virtual Conference Presentation for On-Demand Viewing

  • MINDCURE just announced receiving its HIPAA certification for iSTRYM, its AI-powered, SaaS platform for psychedelic therapy
  • This marks a key milestone for the company, having already exceeded its target of 10 partner clinics by the end of 2021
  • It also inches the company closer to the platform’s commercial deployment, set for the second quarter of 2022
  • This comes just in time, following the appointment of Dr. Doron Sagman as the company’s new CMO
  • MINDCURE’s Life Sciences Virtual Conference Presentation will also be available for on-demand viewing 24/7 for the next 90 days
Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) has been at the forefront of the mental health industry, developing digital therapeutics and researching various psychedelic compounds. Such a blend in its approach has placed the company in a unique position to address these medical needs and stamp its position in the market. In what marks a significant leap towards commercial viability and bringing its products and services even closer to consumers, MINDCURE just announced receiving Health Insurance Portability and Accountability Act (“HIPAA”) certification for its flagship product, iSTRYM (https://ibn.fm/74y1o). iSTRYM is a software-as-a-service (“SaaS”) and artificial intelligence (“AI”)-driven platform that allows for personalized and quantified outcomes in psychedelic therapy. Through this platform, MINDCURE can modernize care, taking it from manual to digital and bringing better treatment outcomes for patients and therapists while keeping costs low for insurers. While making the announcement, Geoff Belair, MINDCURE’s Chief Technology Officer (“CTO”), noted, “We want to be the company that people trust with their minds, and achieving HIPAA is the first step of many in building that trust. At MINDCURE, we passionately defend data privacy and will ensure it is a core part of what we provide.” This HIPAA certification marks the second most significant achievement for the company’s platform, having initially exceeded the announced target of 10 partner clinics by the end of 2021. As of October, MINDCURE had over 20 partnerships with ketamine clinics in nine states in the United States and three provinces in Canada. “Our ability to partner with these clinics serves to validate our confidence in the iSTRYM platform and its value to patients and clinicians,” noted Kelsey Ramsden, the President and Chief Executive Officer (“CEO”) of MINDCURE. With the achievements so far, MINDCURE is confident that it will achieve its goal of commercially deploying the iSTRYM platform within the second quarter of the 2022 calendar year. Additionally, back in August, the company released the minimum viable product (“MVP”) of iSTRYM’s digital therapeutics technology (“DTx”). The objective was to partner with clinics across North America, a move that has yielded notable results that further inform the development of iSTRYM as it plans for the 2022 launch. “Receiving HIPAA compliance is a significant milestone for MINDCURE, which supports our goal of commercially deploying iSTRYM in the second quarter of 2022, as well as generating near-term revenue for the platform,” noted Ms. Ramsden. “We developed iSTRYM as a drug-agnostic tool that we will be able to scale beyond psychedelics and into other therapeutic fields, which could result in additional revenue opportunities for MINDCURE in the future,” she added. This certification comes just in time given the appointment of Dr. Doron Sagman as MINDCURE’s Chief Medical Officer (“CMO”). Dr. Sagman will play an integral role in furthering the company’s mission to reinvent the mental health care model for both patients and practitioners while advancing psychedelic-assisted therapy into common and accepted care (https://ibn.fm/L6JWC). Dr. Sagman lends over 18 years of experience in the pharmaceutical industry, having held leadership positions in clinical development, medical research, medical affairs, and regulatory affairs. He is excited about the industry and is delighted to be part of the MINDCURE team. “We are entering a pivotal and historical phase of medical discovery for patients who suffer from mental health disorders. I am delighted to join MINDCURE’s leadership team and work to advance innovative solutions to best meet unmet mental health needs,” he noted. On December 16, MINDCURE presented at this year’s Life Sciences Virtual Investor Conference. This year’s conference featured live presentations from CEOs and top executives who shared insights into their businesses and investment stories while also answering investors’ questions. All company presentations from the event, including MINDCURE’s, will be available 24/7 for the next 90 days, starting December 20. In addition, advisors, investors, and analysts may download shareholder materials from the company’s “virtual trade booth.” You can register or login to view the presentations here https://ibn.fm/cqG6R For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) CEO Shares Company’s Progress Since Launch, Business Model, Plans for the Future, in Recent EDGE Podcast Interview

  • PlantX President and CEO Lorne Rapkin was recently part of an EDGE Podcast episode hosted by Brandon C. White, an entrepreneur and angel investor
  • Lorne detailed his background and how he joined PlantX
  • The interview explored the company’s growth and progress as well as the factors behind this growth, including acquisitions, marketing campaigns, and going public
  • Lorne also discussed the company’s plans for the future, including adopting a franchising model and investing in warehousing facilities
Since its establishment in 2020, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a company making a mark in the global plant-based scene, has made significant strides. For instance, the company, which started with four personnel, has grown its workforce to over 75 people spread across multiple countries. One of the founding employees, Lorne Rapkin, joined host Brandon C. White, an Entrepreneur and Angel Investor, in a recent EDGE Podcast interview (https://ibn.fm/WAoJK). Lorne, who began his journey at PlantX as its Chief Financial Officer (“CFO”) before becoming its President and Chief Executive Officer (a position he holds to date), shared insights into the progress made since 2020 as well as the company’s vision and plans moving forward. Lorne started the interview by discussing his background as an entrepreneur and Certified Public Accountant (“CPA”). In this role, he amassed a lot of experience dealing with different business owners in various industries as an advisor, a position that helped him gravitate toward leading a company. When PlantX Founder Sean Dollinger, with whom he goes back many years, asked if he would be interested in taking on the CFO role to help guide the young business along the way, Lorne took him up on his offer. The company has only grown since. For instance, PlantX’s revenue increased from $1,349 to $6.5 million within the first year. Lorne credits this growth to the leadership and guidance offered by the then CEO Julia Frank (current COO). Currently, the company generates monthly recurring revenue of over $1.3 million. This growth, Lorne noted, is due to several key factors, among them acquisitions and marketing campaigns. “We have had some successful acquisitions over the past year and even into Q1 of this year – Bloombox Club UK, a juice company out of California (Little West), boutique-style grocery and food preparation company (New Deli), and a restaurant flagship store in Squamish, British Columbia (Locavore Bar & Grill). Certainly, they have helped grow the top-line revenue,” stated Lorne. “We have spent a great deal of time and resources on promoting the brand and the company through partnering with different influencers or doing out-of-the-box marketing campaigns, which has now done what we have set out PlantX to be. It’s not only offering a product but also educating the public on what is living a plant-based lifestyle… [and] also attracting the potential customers and investors to what we are truly about,” Lorne added. In addition, Lorne noted that the company’s move to go public very early on also helped its ability to scale by providing funding for the acquisitions and expansion. Using the funds, PlantX has been able to build out its e-commerce platforms, acquire companies, attract different influencers, and spend the resources needed on its website, accomplishments that are resource-intensive. Lorne also pointed out that the company ruled out traditional ways of raising capital, including taking a loan from the bank or getting funding from venture capitalists. These approaches, Lorne says, would have restricted the company’s growth trajectory to what it is today. At its core, PlantX is an e-commerce business. But the company also offers additional services, such as meal delivery, aided by its brick-and-mortar stores. “The root of our business is e-commerce, and then we have all of these new enhancements where we have flagship stores sitting in Canada, the US, and Israel, where people can come in and purchase grocery items, perishable and non-perishable goods, and plants. We are using those centers for advertising (foot traffic), warehousing and distribution, and education,” Lorne explained. PlantX intends to expand its brick-and-mortar stores business via a franchising model. First, the company plans to establish flagship stores in specific locations – it expects to open new stores in Los Angeles and Israel later in December. Next, PlantX will help people learn about the stores and then sell franchise licenses. Already, there are different interested parties. “If we can show people that this brick-and-mortar model is very attractive; we will have a variety of products – it’s not all going to be food – fitting in these respective stores, which we know will do well just based on our acquisition of New Deli in Venice. We know that there’s a demand, we know what the top-line revenue and margins are, and we know that there’s a great ability to get the businesses to where they need to be, to be profitable,” Lorne continued. Moving forward, the company intends to focus on groceries as the next phase of growth. As a result, PlantX is investing in warehousing facilities, which will allow it to achieve more real-time and efficient deliveries. The company has already secured several strategically located warehouses in Canada and the United States. At the same time, PlantX will also concentrate on its e-commerce business as well as brick-and-mortar stores under the franchising model. For more information, visit the company’s websites at www.PlantX.comwww.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

Miami to Address the Influential North American Bitcoin Conference

Date: January 17-19, 2022 Venue: Miami As the New Year approaches and the Blockchain continue to gain eminence, Keynote invites you to join the world-class Blockchain conference to be held in Miami. The North American Bitcoin Conference, a part of World Blockchain Forum: Investments & ICOs, strives to transform lives through innovation and emerging technology. Bringing the unmissable TNABC back to Miami, Keynote seeks to inspire and enable the Blockchain and crypto community across all skill levels. TNABC features enterprise use-cases, inspirational keynotes, panel discussions, tech-talks, crypto fireside chats, and start-up speed pitches with agenda enlisted key industry leaders to bring you stories of their successes, failures, and to reveal the insights you need to embrace impactful technological change today. The North American Bitcoin Conference 2022 is hosted for its eighth year by Keynote. Learn to lead the disruption and transform the landscape as crypto space continues to evolve across the globe. As the largest and longest-running conferences in the Blockchain space, TNABC will focus on areas like global adoption of Blockchain technology, institutional investments in digital assets, Central bank digital currencies (“CBDCs”), Decentralized Finance (“DeFi”), geopolitical threats and opportunities in Blockchain (inc. regulatory sandboxes, restrictions), stablecoins, and more. Be a part of a conference that is redefining innovation and networking opportunities. Blockchain industry speakers will be presenting throughout this two-day conference. Business titan Mark Cuban will join crypto-friendly Miami Mayor, Francis Suarez as the keynote speaker at The North American Bitcoin Conference. Other speakers include:
  • Peter Smith, Founder & CEO, Blockchain.com
  • Bill Barhydt, CEO & Founder, Abra
  • Charlie Shrem, Host, UntoldStories
  • Nick Spanos, Bitcoin Pioneer
  • David Schwartz, CTO, Ripple
  • Michael Kong, CEO, Fantom Foundation
  • Kathleen Breitman, Co-Founder, Tezos
  • Alex Mashinsky, CEO, Celsius Network
  • Matthew Roszak, Chairman & Co-Founder, Bloq
  • Craig Sellars, Co-Founder, Tether
  • Ran Neu-Ner, Host, Crypto Banter
  • Moe Levin, CEO & Founder, Keynote
  • Alan Goren, Founding Partner, Draper Goren Holm
Establishment of Blockchain Uprising Join the creators and the innovators who are revolutionizing the crypto industry. Whether you’re bootstrapped or blue chip, this conference enables you to refine your goals and achieve the best possible outcomes for your business. With a select audience of financial executives, a stunning venue, and an experienced speaker line-up, TNABC offers a unique opportunity to present your brand and help shape the Blockchain ecosystem. Get a ticket and see the future unfold in real-time! For more information about the conference, please visit www.BTCMiami.com.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) to Open 2 New Ketamine Infusion Clinics; Co-Founder and CEO Matt Stang Reveals Investor Relations Efforts

  • Delic Holdings subsidiary, Ketamine Wellness Centers, announced plans to open two new clinics in the coming weeks
  • The clinics, to be located in Salt Lake City, Utah and Reno, Nevada will take KWC’s total clinic count to 14, forming part of the company’s plan to open 13 new ketamine infusion clinics across the country over the next 18 months
  • Following Delic’s keynote ‘Meet Delic’ conference on Nov. 6-7, CEO Matt Stang announced plans to attend the upcoming HC Wainwright Bioconnect Virtual Conference as well as CEM’s 8th annual AlphaNorth Capital Conference in January 2022
Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leading psychedelic wellness platform committed to bringing science-backed benefits to its many stakeholders, has revealed that its wholly owned ketamine infusion clinic chain, Ketamine Wellness Centers LLC (“KWC”), will open two new clinics in Salt Lake City, Utah and Reno, Nevada, by February 2022. Ketamine Wellness Centers LLC, which was acquired by Delic Holdings in September 2021, currently boasts 10 ketamine infusion treatment clinics located across eight U.S. states, having cumulatively delivered over 60,000 treatments to date across Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas and Washington. KWC’s Salt Lake City clinic, which is set to be located in the suburb of Taylorsville at 6087 South Redwood Road, is expected to open on Jan. 10, 2022. With a capacity of up to seven treatment rooms, the facility will be one of KWC’s largest clinics in the U.S. Meanwhile, KWC Reno, which is scheduled to open in February 2022, will be the company’s second clinic in Nevada and has been strategically located to serve both local Nevada residents as well as patients domiciled in the larger California markets who currently do not have access to affordable in-state providers. “Offering accessible, personalized and high-quality care is integral to Ketamine Wellness Centers’ mission, and we look forward to supporting the emotional wellness of new patients in Utah and Nevada,” said Kevin Nicholson, CEO of KWC and Chief Operating Officer for Delic. Delic will open 13 ketamine infusion clinics across the country over the next 18 months, adding to the company’s existing portfolio which comprises of 12 KWC clinics as well as two clinics operated by subsidiary, Ketamine Infusion Centers LLC (“KIC”), with the latter centers located in California and Arizona, respectively.  As such, the company plans to further expand access to millions who can now benefit from new medicines and treatments for a broad array of mental health conditions, building on the company’s reputation as a central hub of education, media and cultural conversations around these novel treatments. Delic Holdings also seized on the opportunity to announce further details regarding Matt Stang, Delic’s co-founder and CEO’s participating at the upcoming HC Wainwright Bioconnect Virtual Conference as well as CEM’s 8th annual AlphaNorth Capital conference in January. Stang will present at the HC Wainwright Bioconnect Virtual Conference, which will take place digitally between Jan. 10-13, 2022. At the conference, Stang is set to elaborate on Delic’s expansion strategy and industry outlook heading into the new year in addition to hosting one-on-one meetings with investors. To access Delic’s presentation at the virtual HC Wainwright Bioconnect Conference, investors can register at the following link: https://hcwevents.com/bioconnect/ Matt Stang is also set to attend CEM’s 8th Annual AlphaNorth Capital Conference, which is set to be held in Nassau, Bahamas on Jan. 21-23, 2022. The conference has garnered a well-established reputation for connecting growth-stage companies — including those within technology and biotech — with high-level investors. Stang will host one-on-one meetings that will enable investors to gain closer insights into Delic’s growth opportunities in the coming year. Investors and issuers interested in registering for the attendee waitlist can visit https://cem.ca/conference/alphanorth-capital-event/. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

Growth of Point-of-care Lab Testing Means Blue Sky Opportunity for Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) as its Platform Continues to Roll Out

  • Pharmacy services developer Avricore Health is establishing a network of lab-grade testing and reporting for select medical conditions through neighborhood pharmacy stores
  • Such neighborhood POC store solutions building empowers patients to work with trained pharmacy professionals in monitoring select health conditions, including virus exposure
  • Viruses have become a focal point of health response efforts during the past two years as COVID-19 SARS-CoV-2 infections have claimed millions of lives and sickened scores of others
  • Avricore has thus far established its pilot program in Canada’s eastern Ontario province and western British Columbia province, anticipating strong growth of the HealthTab network in Canada and internationally in 2023
The global COVID health crisis has illuminated the importance of the medical sciences like never before as the populations of virtually every nation have monitored news updates on the progress of infectious disease rates, visited local health departments to receive vaccinations, and debated the effectiveness of health policy measures on social media. The vaccination efforts by local health departments have extended to the street, with mobile shot clinics and education strategies independent of primary caregiver offices. In real time, the organization of the COVID response plan has demonstrated the potential of point-of-care (“POC”) testing and POC analysis of lab results. Americans interested in the advent of COVID-19 home test kits have overwhelmed resources in many places, particularly as the holiday season has generated a spike in family and neighbor gatherings to celebrate, leading major pharmacy chains to ration individual purchases of the kits (https://ibn.fm/aEalA). Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is a health diagnostics solutions innovator dedicated to expanding access to lab-grade medical test results for a wide variety of medical conditions, including potential COVID analysis. Avricore’s trademarked HealthTab platform brings together a baker’s list of corporate resources that make up the recipe for patients’ active participation in their own medical care. Multinational medical devices and health care company Abbott Laboratories has agreed to let Avricore distribute its handheld blood chemistry analyzer, for example, under Avricore’s pilot rollout of its accessible lab test program at several Canadian Shoppers Drug Mart pharmacies, using Abbott’s trademarked ID Now kiosks. HealthTab provides the nerve fibers through which the program’s messages travel. “We‘ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in pharmacy,” Avricore Health CEO Hector Bremner stated earlier this year (https://ibn.fm/9Rk8q). “We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.” In the process, Avricore is simultaneously rewarding patients interested in maintaining their well-being and pharmacies concerned about their bottom line, particularly in Canada where passage of the Pan-Canadian Select Molecule Price Initiative for Generic Drugs in 2018 turned out to be a money-losing effort for the corner drug stores as it reduced retail margins in reimbursements. The HealthTab platform provides lab results for monitoring pre-diabetes and cardiovascular conditions, as well as viruses such as COVID’s SARS-CoV-2, RSV, influenza A and B, and strep. As enthusiasm for point-of-care testing continues to grow, patients find it easier to visit a neighborhood pharmacy and monitor their blood chemistry on a regular basis to identify concerns in regard to their own conditions. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Increasing Gold, Silver Mining Assets, as Investors Eye Precious Metals To Counter Inflation

  • StraightUp is expected to benefit from increased interest in precious metals as investors, traders, and savers rush into gold and silver markets to hedge against inflation, which has risen to its highest point since 1982
  • Economists expect that the strong inflation will continue driving buyers into gold and other precious metals
  • StraightUp is acquiring various gold and silver mineral property assets in historically prolific regions of both North and South America
The latest data released December 10 by the Bureau of Labor Statistics show the US inflation rate rose to 6.8%, its highest point since 1982, on the back of higher housing, food, and gas prices. The price hikes are attributable to the pandemic, which disrupted and continues to affect manufacturing and shipping. At the same time, Americans have more cash to spend due to the US government’s stimulus payment program. This has burdened supply chains even further, bumping up inflation numbers (https://ibn.fm/90wSw). Economists are, however, wary that the country’s inflation is no longer in the “transitory” ballpark. Instead, they opine that the Federal Reserve (“the Fed”), which is congressionally mandated to tame inflation, is losing control of the impermanence narrative of the current hot figures. Ironically, the Fed is said to be eager to see inflation numbers move even higher because that would make otherwise unsustainable debt loads more sustainable by reducing their real value – borrowing vast amounts of money is appealing provided interest rates remain below the inflation rate. But according to a recent Money Metals article (https://ibn.fm/OwttD), this presents a challenge. The write-up observes that debt can work out great for leveraged speculators in financial markets until it no longer does. “At some point, interest rates will rise… Asset classes that have been heavily bid up by leveraged speculation include stocks, real estate, and even cryptocurrency. When the next round of deleveraging takes hold, these and other financial assets will be vulnerable to forced selling. By contrast, precious metals markets have seen very little speculative buying of late,” the article reads. The article notes that as inflation eats away the value of financial assets, hard assets such as gold and silver are likely to garner the attention of investors. In November, in spite of normal and expected ups and downs, gold prices rallied to a near-five-month high after high consumer price data prompted people to buy gold as a hedge against inflation (https://ibn.fm/xFXOJ). Economists expect that strong inflation will continue to drive buyers into gold, while others observe that the Fed’s hands are tied – any remedial efforts are only likely to compound the situation. As this happens, the gold market is expected to continue on a bullish trend, with the resultant price rally expected to benefit StraightUp Resources (CSE: ST) (OTCQB: STUPF), a public company engaged in mineral exploration as well as the acquisition of mineral property assets with significant potential in North and South America. Its North American assets are spread across the United States and Canada, with some of its properties – the RLX North and RLX South – located in the prolific Red Lake Mining District, which boasts a rich history having produced more than 30 million ounces of gold (https://ibn.fm/VS3rd). The company also has other key projects – the Bear Head Gold Project and Ferdinand Gold Project – extending along the same Greenstone Belt into the neighboring Meen-Dempster Greenstone Belt located in Uchi Subprovince. In addition, in September, StraightUp acquired the historic West Cat Mine in Nevada that includes an unpatented lode mining claim in the historic Beatty Mountain Nevada Mining District (https://ibn.fm/bmGsN). In October, the company secured a right of exclusivity to negotiate an agreement to acquire Premier Silver Corp (“PSC”), which owns one of the largest silver mining land packages as well as a processing plant in Peru, collectively known as the Mallay assets (https://ibn.fm/zq96t). The property was developed, capitalized, and permitted by Buenaventura (NYSE: BVN), a multibillion-dollar globally recognized mining company that adheres to the highest industry standards. As an asset, Mallay offers a high level of operationality. It put PSC, which acquired it in 2020, in a unique position to provide the market-leveraged exposure to the silver industry. StraightUp’s potential acquisition of PSC is expected to have a similar effect. With assets capable of producing silver and gold, StraightUp appears poised to benefit from the inflation-triggered interest in precious metals as investors, savers, and traders seek alternatives to cash. For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

SRAX Inc. (NASDAQ: SRAX): The Go-To Data Provider for Investors and Public Companies

  • SRAX’s Sequire SaaS platform, and popular investors and industry conferences, provide unique opportunities for investors and public companies to connect and communicate
  • The 2021 Sequire Clean Tech & Electric Vehicles Conference was held on December 6th, featuring panels, keynote speakers, and corporate presentations from some of the cleantech industries brightest minds
  • Investors can still access the complete conference via the conference website
Without question, everyone today is looking for an investment edge. Investors crave transparency and succinct, actionable insight into genuine growth opportunities. Companies are on a relentless quest to better understand and communicate with their shareholders, as well as the broad investment community. The evolution of the digital world we live in today has simultaneously made things easier and more difficult for both sides of the investment paradigm. That’s where fintech SRAX (NASDAQ: SRAX) comes in to make the opaque clear, providing its Sequire Software-as-a-Service (SaaS) platform for public companies, as well as preeminent conferences where investors can follow favorite companies and meet others that they may have been unfamiliar with. Sequire is a big data analytics platform that allows public companies the ability to track the buying and selling activity of its investors, subsequently using the information to engage its investor base across different marketing channels. The platform gives management a clear view of important data, such as market maker activity, buying/selling trends, new shareholders, and breakdowns of shareholder positions, all of which can be analyzed to understand market activity and responses to developments and campaigns. Sequire’s utility is multi-fold, unearthing analytics to deliver unbiased data for companies so they can manage and monitor ROI from investor relations programs and corporate communication firms. Built-in communication tools compile contact lists from reports and events for direct outreach. Companies are also able to combine verified and historical stock data to target relevant investors across programmatic and social channels. Covering the gambit of investor relations, Sequire naturally dovetails with other components of SRAX’s model, namely its investor conferences. The company owns LD Micro, perhaps the best known and most respected conference provider serving the small and micro-cap markets, as well as hosts industry conferences under the Sequire banner. This month featured the 2021 Sequire Clean Tech & Electric Vehicles Conference, a preeminent virtual investor event, held on Dec. 6. The elite event featured discussions with key leaders and executives covering topics such as EVs, energy and power, materials, and chemicals, amongst others, and presentations from over two dozen public cleantech companies where they were given a platform to showcase their innovations. Presenters ranged from tiny companies with market capitalizations around $3 million trading on the over-the-counter markets, to those on national exchanges with market caps into the multi-hundreds of millions of dollars. Interested parties still have the opportunity to access all the events from the conference, including The Future of Electronic Vehicles Panel, a discussion on Investing in the EV Sector in 2022 with Michael Shlisky or any of the corporate presentations. The digital space is chock-full of an unimaginable amount of content and information. While it certainly beats the alternative, the data space can also make the investment world more difficult to navigate, a situation that SRAX aims to rectify with platforms for all involved to concisely connect. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Reports Strong Third Quarter 2021 Financial Results; Sees Revenues Soar by Upwards of 1,000% YoY

  • BevCanna Enterprises recently published its unaudited financial results for the third quarter of 2021
  • The company recorded over 1,000% revenue growth year-over-year which separately recording positive gross profit for the quarter
  • In addition to receiving its initial orders from the British Columbia, Alberta and Ontario Cannabis Distribution companies, BevCanna has also signed an agreement with UNFI Canada – thus leading to a significant expansion in its geographical distribution footprint across Canada
  • BevCanna also announced the acquisition of Embark Health Inc, a leader in solventless cannabis extraction, as it actively diversifies from its core beverage manufacturing business
BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, has recently reported its unaudited financial results for the fiscal quarter ended September 30, 2021. BevCanna announced that the company saw revenues rise by upwards of 1,000 percent to $1.1 million over the quarter with gross profit of $356,168, a significant turnaround from the loss of $40,280 recorded in the equivalent quarter of 2020. BevCanna has recorded a number of operational highlights over the past few weeks, contributing to the company’s top-line revenue growth – a key driver of which has been the obtention of initial product listings and purchase orders from the British Columbia Liquor Distribution Branch (“BCLDB”), Alberta Gaming and Liquor Commission and the Ontario Cannabis Store, which in turn have resulted in shipments to British Columbia and Ontario delivered over the course of the quarter. Subsequent to the end of the quarter, the company revealed that its initial shipment of the award-winning Keef Brands line of cannabis-infused beverages to the BCLDB had benefited from a surge of consumer interest, with the initial shipment completely sold out via the BCLDB’s online platform. “As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000 per cent, achieving $1.1 million in sales, compared to $94,000 in the year ago quarter,” commented John Campbell, Chief Financial Officer of BevCanna. “Our third quarter results are further evidence of the Company’s continued execution and the impact that our brands are having on the market. BevCanna Enterprises has also worked towards broadening its product portfolio, recently signing agreements with The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX: TNYBF), Averi Health Products and Xebra Brand Ltd for the manufacture of their respective products for distribution within the Canadian market. To that end and to further its distribution footprint within the nation, BevCanna separately announced that it had finalized an agreement with leading North American wholesale distributor, United Natural Foods, Inc. (“UNFI”). Pursuant to the agreement, UNFI Canada will carry and distribute BevCanna’s product portfolio, resulting in significant expansion to the company’s growing network of over 3,000+ points of retail distribution across the country. Lastly, BevCanna Enterprises also revealed that it has arrived at a definitive agreement to acquire Embark Health Inc (“Embark”), a leader within the field of solventless cannabis extract and enhanced delivery technology, with a focus on the formulation and production of advanced cannabis 2.0 products for the B2B, medical and adult-use markets. The agreement will provide BevCanna Enterprises with further impetus in its bid to diversify its business line away from its current focus on plant-based and cannabinoid beverages and supplements and towards a more expansive and wide-ranging product portfolio. “Our unique and diverse portfolio continues to expand, and with the impending close of our acquisition of Embark, will include an even wider range of adult-use and wellness channels and innovative product categories,” continued Mr. Campbell. “We look forward to welcoming Embark and its team and remain laser-focused on our go-forward organic growth, while continuing to pursue complementary acquisitions, with the goal of further diversifying our brand offerings in the health and wellness categories.” For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

From Our Blog

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Anticipating Tomorrow’s Imaging Standards Today

September 26, 2025

In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a […]

Rotate your device 90° to view site.